These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 34282776)

  • 1. Epitranscriptomics: A New Layer of microRNA Regulation in Cancer.
    De Paolis V; Lorefice E; Orecchini E; Carissimi C; Laudadio I; Fulci V
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epitranscriptome in miRNAs: Crosstalk, Detection, and Function in Cancer.
    Del Valle-Morales D; Le P; Saviana M; Romano G; Nigita G; Nana-Sinkam P; Acunzo M
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitranscriptomic orchestrations: Unveiling the regulatory paradigm of m6A, A-to-I editing, and m5C in breast cancer via long noncoding RNAs and microRNAs.
    Yin Q; Qu Z; Mathew R; Zeng L; Du Z; Xue Y; Liu D; Zheng X
    Cell Biochem Funct; 2024 Apr; 42(3):e3996. PubMed ID: 38561942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives.
    Imbriano C; Moresi V; Belluti S; Renzini A; Cavioli G; Maretti E; Molinari S
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitranscriptomics in parasitic protists: Role of RNA chemical modifications in posttranscriptional gene regulation.
    Catacalos C; Krohannon A; Somalraju S; Meyer KD; Janga SC; Chakrabarti K
    PLoS Pathog; 2022 Dec; 18(12):e1010972. PubMed ID: 36548245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring epitranscriptomics for crop improvement and environmental stress tolerance.
    Yang X; Patil S; Joshi S; Jamla M; Kumar V
    Plant Physiol Biochem; 2022 Jul; 183():56-71. PubMed ID: 35567875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-to-date on the evidence linking miRNA-related epitranscriptomic modifications and disease settings. Can these modifications affect cross-kingdom regulation?
    Tomé-Carneiro J; de Las Hazas ML; Boughanem H; Böttcher Y; Cayir A; Macias González M; Dávalos A
    RNA Biol; 2021 Nov; 18(sup2):586-599. PubMed ID: 34843412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology.
    Amalric A; Bastide A; Attina A; Choquet A; Vialaret J; Lehmann S; David A; Hirtz C
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):1-18. PubMed ID: 34473579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitranscriptomics: An Additional Regulatory Layer in Plants' Development and Stress Response.
    Shoaib Y; Usman B; Kang H; Jung KH
    Plants (Basel); 2022 Apr; 11(8):. PubMed ID: 35448761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of RNA modification in hepatocellular carcinoma.
    Feng Q; Wang D; Xue T; Lin C; Gao Y; Sun L; Jin Y; Liu D
    Front Pharmacol; 2022; 13():984453. PubMed ID: 36120301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
    Liu Y; Zhu J; Ding L
    Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Census and Categorization Method of Epitranscriptomic Marks.
    Mathlin J; Le Pera L; Colombo T
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisulphite miRNA-seq reveals widespread CpG and non-CpG 5-(hydroxy)methyl-Cytosine in human microRNAs.
    Carissimi C; Laudadio I; Lorefice E; Azzalin G; De Paolis V; Fulci V
    RNA Biol; 2021 Dec; 18(12):2226-2235. PubMed ID: 33980133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of epitranscriptomic marks in the cardiovascular system and disease: a narrative review.
    Ilieva M; Uchida S
    Ann Transl Med; 2022 Jul; 10(13):753. PubMed ID: 35957723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current technical advancements in plant epitranscriptomic studies.
    Xie Y; Chan LY; Cheung MY; Li MW; Lam HM
    Plant Genome; 2023 Dec; 16(4):e20316. PubMed ID: 36890704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of RNA modifications in plant RNA polymerase II transcripts: highlights and perspectives.
    Zimna M; Dolata J; Szweykowska-Kulinska Z; Jarmolowski A
    J Exp Bot; 2023 Aug; 74(14):3975-3986. PubMed ID: 37076273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.